Merck & Co., Inc.MRKNYSE
Loading
Operating Expenses Over TimeStable
Percentile Rank86
3Y CAGR+3.6%
5Y CAGR+3.2%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+3.6%/yr
vs +4.4%/yr prior
5Y CAGR
+3.2%/yr
Consistent
Acceleration
-0.8pp
Decelerating
Percentile
P86
Within normal range
vs 5Y Ago
1.2x
Modest growth
Streak
2 yr
Consecutive declineStable
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $26.20B | -8.9% |
| 2024 | $28.75B | -29.9% |
| 2023 | $41.03B | +74.0% |
| 2022 | $23.59B | +7.8% |
| 2021 | $21.88B | -2.1% |
| 2020 | $22.35B | +16.5% |
| 2019 | $19.18B | -3.4% |
| 2018 | $19.85B | -2.7% |
| 2017 | $20.41B | +0.7% |
| 2016 | $20.28B | - |